Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer

International Journal of Oncology

Volumn 39, Issue 4, 2011, Pages 955-963

  Kim, Ju Hee ^a   Kang, Han Sung ^b   Kim, Tae Woo ^a   Kim, Sun Jung ^a  

^a Dongguk University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Breast cancer; CpG island; Differential methylation hybridization; Methylation; STAT1

Indexed keywords

STAT1 PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CPG ISLAND; DIFFERENTIAL METHYLATION HYBRIDIZATION; DNA FINGERPRINTING; DNA HYBRIDIZATION; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; GENE CONTROL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYBRIDIZATION, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 79960854106     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1075     Document Type: Article

References (41)

1. Liu B, Tahk S, Yee KM, Fan G and Shuai K: The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science 330: 521-525, 2010.
2. Maegawa S, Hinkal G, Kim HS, et al: Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res 20: 332-340, 2010.
3. Ai L, Kim WJ, Kim TY, et al: Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res 66: 7899-7909, 2006. (Pubitemid 44299152)
4. Cao Y, Vo T, Millien G, et al: Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene. J Biol Chem 285: 2152-2164, 2010.
5. Yan PS, Shi H, Rahmatpanah F, et al: Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 63: 6178-6186, 2003. (Pubitemid 37255161)
6. Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD and Richardson AL: BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91: 179-186, 2005. (Pubitemid 40684930)
7. Yu J, Koujak S, Nagase S, et al: PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27: 4657-4665, 2008.
8. Wolf I, O'Kelly J, Rubinek T, et al: 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res 66: 7818-7823, 2006. (Pubitemid 44289243)
9. Singh P, Yang M, Dai H, et al: Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers. Mol Cancer Res 6: 1710-1717, 2008.
10. Ito Y, Koessler T, Ibrahim A, et al: Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet 17: 2633-2643, 2008.
11. Kim TW, Kim YJ, Lee HJ, Min SY, Kang HS and Kim SJ: Hs.137007 is a novel epigenetic marker hypermethylated and up-regulated in breast cancer. Int J Oncol 36: 1105-1111, 2010.
12. Yan PS, Perry MR, Laux DE, Asare AL, Caldwell CW and Huang TH: CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res 6: 1432-1438, 2000. (Pubitemid 30226231)
13. Huang TH, Perry MR and Laux DE: Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8: 459-470, 1999. (Pubitemid 29097334)
14. Tommasi S, Karm DL, Wu X, Yen Y and Pfeifer GP: Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 11: R14, 2009.
15. Li L, Lee KM, Han W, et al: Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Hum Mol Genet 19: 4273-4277, 2010.
16. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037, 2005. (Pubitemid 41486985)
17. Lu L, Katsaros D, de la Longrais IA, Sochirca O and Yu H: Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67: 10117-10122, 2007. (Pubitemid 350070782)
18. Kim HS and Lee MS: STAT1 as a key modulator of cell death. Cell Signal 19: 454-465, 2007. (Pubitemid 46107818)
19. Xi S, Dyer KF, Kimak M, et al: Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst 98: 181-189, 2006. (Pubitemid 43205480)
20. Lan L, Han H, Zuo H, et al: Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis. Int J Cancer 126: 53-64, 2010.
21. Kawaguchi-Ihara N, Murohashi I, Nara N and Tohda S: Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3A. Anticancer Res 28: 2701-2704, 2008.
22. Yan X and Chen YG: Smad7: not only a regulator, but also a crosstalk mediator of TGF-β signalling. Biochem J 434: 1-10, 2011.
23. Alarmo EL, Kuukasjärvi T, Karhu R and Kallioniemi A: A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 103: 239-246, 2007.
24. Teschendorff AE, Menon U, Gentry-Maharaj A, et al: An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 4: E8274, 2009.
25. Kim SJ, Kelly WK, Fu A, et al: Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer. Cancer Lett 302: 47-53, 2011.
26. Deneberg S, Grövdal M, Karimi M, et al: Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia 24: 932-941, 2010.
27. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al: Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk Res 32: 487-490, 2008. (Pubitemid 351308023)
28. Eden A, Gaudet F, Waghmare A and Jaenisch R: Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300: 455, 2003. (Pubitemid 36444319)
29. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al: Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24: 7213-7223, 2005. (Pubitemid 41679283)
30. Kamalakaran S, Varadan V, Giercksky Russnes HE, et al: DNA methylation patterns in luminal breast cancers differ from nonluminal subtypes and can identify relapse risk independent of other clinical variables. Mol Oncol 5: 77-92, 2011.
31. Ruike Y, Imanaka Y, Sato F, Shimizu K and Tsujimoto G: Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 11: 137, 2010.
32. McCabe MT, Lee EK and Vertino PM: A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. Cancer Res 69: 282-291, 2009.
33. Loss LA, Sadanandam A, Durinck S, et al: Prediction of epigenetically regulated genes in breast cancer cell lines. BMC Bioinformatics 11: 305, 2010.
34. Darnell JE: STATs and gene regulation. Science 277: 1630-1635, 1997.
35. Kaplan DH, Shankaran V, Dighe AS, et al: Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95: 7556-7561, 1998. (Pubitemid 28293291)
36. Huang S, Bucana CD, Van Arsdall M and Fidler IJ: Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 21: 2504-2512, 2002. (Pubitemid 34438103)
37. Yu H and Jove R: The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 4: 97-105, 2004. (Pubitemid 38198738)
38. Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C and Doppler W: Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8: 3065-3074, 2002. (Pubitemid 35155015)
39. Sharma G, Mirza S, Parshad R, et al: Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol 32: 23-32, 2011.
40. Lu S and Archer MC: Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells. Int J Cancer 126: 416-425, 2010.
41. Papageorgis P, Lambert AW, Ozturk S, et al: Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res 70: 968-978, 2010.